[Ip-health] Webinar: Extending monopolies: evidence from Brazil and Europe on the impact on innovation and access to medicines, June 25

Marcela Vieira marcelacfvieira at gmail.com
Thu Jun 18 02:04:58 PDT 2020

Dear all,

We would like to invite you to the next webinar of the series organized by
the Knowledge Network for Innovation and Access to Medicines, a project of
the Global Health Centre at the Graduate Institute of Geneva, which will
take place on Thursday, June 25,  4pm - 5pm CEST / 11h-12h BRT.

We hope you will be able to join us for this discussion. The webinar will
be recorded and made available a few days after it takes place. A list of
the previous webinars of the series and their recordings and related
materials is available at: https://www.knowledgeportalia.org/webinars

*Extending monopolies: evidence from Brazil and Europe on the impact on
innovation and access to medicines*
Thursday, June 25, 4pm - 5pm CEST / 11h-12h BRT
To join the webinar, please register here:

- Julia Paranhos, Associate Professor, Economics Institute of the Federal
University of Rio de Janeiro
- Ellen ‘t Hoen, Director, Medicines Law & Policy

- Paranhos, J.; Mercadante, E.; Hasenclever, L. O custo para o SUS da
extensão da vigência de patentes de medicamentos. Cadernos de Saúde
Pública, forthcoming. Executive summary in English (Public health system
increasing costs due to the extension of drug patents terms:
- ‘t Hoen Ellen et al., EU Review of Pharmaceutical Incentives: Suggestions
for Change. Medicines Law and Policy, 2019.

Exclusivity rights, such as patents, data exclusivity and other forms of
market exclusivities, have been used as an incentive to promote
pharmaceutical innovation by granting temporary monopolies over
innovations. However, they have often resulted in high medicine prices and
have not necessarily led to the health-needed innovations they were meant
to incentivize.

Julia Paranhos will present a study on the costs of patent term extensions
to the public health system in Brazil and implications for ongoing policy
and judicial discussions. She will discuss a case in the Brazilian Supreme
Court challenging the constitutionality of such extensions in light of the
public interest. Ellen ‘t Hoen will present a study on how market
exclusivities have affected access to medicines and innovation in Europe.
She will offer recommendations for changes to current policies on
Supplementary Protection Certificates, Data Exclusivity, and Orphan
Medicinal Product regulations.

The webinar is free and open to the public and will be held in English.
Participants will be able to pose questions orally or in writing, and the
speakers will respond to a selection of these during the second half of the
event. Recordings of all webinars will be made available afterward at the
Knowledge Portal on Innovation and Access to Medicines, a project of the
Global Health Centre, Graduate Institute of Geneva. After registering, you
will receive a confirmation email with additional information on how to
join the webinar using the Zoom platform. You can sign up to receive our
newsletter by selecting the “global health box” at

Marcela Vieira
Researcher and Project Coordinator of the
Knowledge Network for Innovation and Access to Medicines

Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira at graduateinstitute.ch

More information about the Ip-health mailing list